Biophytis S.A. (NASDAQ: BPTS) stock fell -2.84% on Monday to $1.37 against a previous-day closing price of $1.41. With 6478.0 shares changed hands, the volume of the stock remained lighter than its average volume of 0.46 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.4100 whereas the lowest price it dropped to was $1.3700. The 52-week range on BPTS shows that it touched its highest point at $9.02 and its lowest point at $1.21 during that stretch. It currently has a 1-year price target of $150.00. Beta for the stock currently stands at 0.99.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BPTS was down-trending over the past week, with a drop of -5.52%, but this was down by -6.80% over a month. Three-month performance dropped to -47.06% while six-month performance fell -71.35%. The stock lost -81.95% in the past year, while it has lost -65.33% so far this year.
Float and Shares Shorts:
At present, 5.37 million BPTS shares are outstanding with a float of 2.97 million shares on hand for trading. On Aug 30, 2023, short shares totaled 68900.0, which was 1.28% higher than short shares on Jul 30, 2023.
Through their ownership of 0.00% of BPTS’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of BPTS, in contrast to — held by mutual funds. Shares owned by individuals account for –.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BPTS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With BPTS analysts setting a high price target of $139.50 and a low target of $4.10, the average target price over the next 12 months is $71.80. Based on these targets, BPTS could surge 10082.48% to reach the target high and rise by 199.27% to reach the target low. Reaching the average price target will result in a growth of 5140.88% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.